Journal of Microbiological Methods

Size: px
Start display at page:

Download "Journal of Microbiological Methods"

Transcription

1 Ž. Journal of Microbiological Methods elsevier.comrlocaterjmicmeth Ne immunoassay for the detection of Helicobacter pylori infection compared ith urease test, 13 C breath test and histology: validation in the primary care setting C.F. Weijnen a,), H.A. Hendriks a,b, A.W. Hoes a, W.M. Vereij b, T.J.M. Verheij a, N.J. de Wit a a Julius Center for General Practice and Patient Oriented Research, UniÕersity Medical Center Utrecht, Location Stratenum, 6th Floor, UniÕersiteitseg 100, 3584 CG Utrecht, Netherlands b Stichting Artsenlaboratorium, Utrecht, Netherlands Received 17 April 2001; accepted 23 April 2001 Abstract Helicobacter pylori plays a major role in peptic ulcer disease and, as a result, testing for H. pylori infection among patients ith dyspepsia has often been advocated. The aim of the study as to determine the diagnostic accuracy, the analytical performance, and optimal cut-off point of a ne serological assay, the Pyloriset EIA-G III for the detection of H. pylori infection in the primary care setting. For 113 primary care patients ith dyspepsia urea breath test, CLOe test, histology and serology tests ere performed. Diagnostic accuracy of the Pyloriset EIA-G III as evaluated against a reference standard of a carbon urea breath test Ž CUBT., CLOe test and histology Ž from gastric biopsies.. Precision, linearity and correlation of the serological assay ith the CUBT and former Pyloriset ere also determined. At the optimal cut-off level of 40 Urml, the positive predictive value as 92.1%, negative predictive value 96.3%, sensitivity 87.5%, and specificity 93.9%. The ithin-run precision as high. The recovery data ere good. The correlation of both CUBT and the former Pyloriset EIA-G and the Pyloriset EIA-G III as high. At the cut-off level of 40 Urml, the ne Pyloriset EIA-G III is a reliable method to detect H. pylori infection in the primary care setting. q 2001 Elsevier Science B.V. All rights reserved. Keyords: Helicobacter pylori; Serology; Diagnostic tests; Family practice 1. Introduction ) Corresponding author. Tel.: q ; fax: q address: c.f.eijnen@med.uu.nl Ž C.F. Weijnen.. The bacterium Helicobacter pylori is knon to play a major role in the development of peptic ulcer disease. Infection ith this spiral, urease producing bacterium causes histological gastritis and is an important risk factor for the development of gastric r01r$ - see front matter q 2001 Elsevier Science B.V. All rights reserved. Ž. PII: S

2 236 ( ) C.F. Weijnen et al.rjournal of Microbiological Methods adenocarcinoma and lymphoma ŽNIH, 1994; Marshall and Warren, 1984; Parsonnet, 1993; Eslick et al., Screening the hole general population for infection ith H. pylori does not appear to be cost-effective, but case finding in certain risk groups, i.e. patients ith active ulcers, a history of ulcers, or gastric mucosa-associated lymphoid tissue lymphoma is indicated ŽPeterson et al., 2000; EHPSG, Many invasive and non-invasive methods are available for the detection of H. pylori infection. Invasive methods require an endoscopy to obtain biopsies of gastric tissue, in hich H. pylori can be diagnosed by urease activity, histology or culture of the bacterium. Endoscopy is an inconvenient and expensive method of H. pylori testing Žapproxi- mately EURO 250 per endoscopy including invasive H. pylori testing. and reliable non-invasive methods could be of great help, notably in the primary care setting. Noninvasive techniques to detect bacterial infection include carbon urea breath tests Ž CUBT., antigen stool tests and anti-h. pylori antibody detection by serological methods ŽVaira et al., 1999; Savarino et al., The antigen stool test is promising but needs further validation in different patient settings. The 14 C-UBT is a simple and reliable test, but the radioactive component restricts its practical use. The 13 C-UBT does not have the disadvantage of radioactivity, but requires the availability of an expensive mass spectrometer, resulting in a 13 total cost of EURO 45 per C-UBT Žpersonnel, equipment and materials.. The test characteristics of most office tests, such as hole blood tests, are disappointing ŽQuartero et al., 2000; Jones et al., A fast and reliable test method to diagnose H. pylori infection is to test for antibodies to the antigen of H. pylori. The enzyme immunoassay is the most common used serological test, because it is a reliable, fast and lo cost technique Žper test approximately EURO 11 for personnel, equipment and materials.. Many serological kits for the detection of H. pylori-specific IgG antibodies are no commercially available Ž Laheij et al., 1998; Wilcox et al., The aim of this study as to investigate the analytical performance and reliability of a ne serological assay, the Pyloriset EIA-G III, for the detection of H. pylori infection in the primary care setting. We investigated its test characteristics and analytical performance against a reference standard of CUBT and invasive tests, and against the former Pyloriset, and determined the optimal cut-off level for the ne test. 2. Materials and methods 2.1. Patients Patients ere recruited from general practices in the city of Utrecht, the Netherlands. Eligible for the study ere patients that presented themselves to their GP ith dyspepsia lasting for at least 2 eeks and ere G 18 years old. Pregnant patients and patients ith pulmonal or cardiac comorbidity ere excluded. The patients ere referred to the local primary care laboratory for serological screening for H. Ž pylori infection Pyloriset EIA-G and Pyloriset EIA-G III, Orion Diagnostica, Espoo, Finland.. At the same visit, the patients also underent a 13 C urea breath test ŽPylobactelle, BSIArTorbet, Chatham, U.K..; the breath-test samples ere analysed and results ere expressed as 13 CO r 12 2 CO2 concentra tions Žan increase in CO2r CO 2, concentrations from baseline of more than 3.5 as required for an established H. pylori infection.. Subsequently, patients ere referred to the local hospital for endoscopy, during hich biopsy samples ere taken for histology Žusing Giemsa or haematoxylinreosin stain., and a rapid urease test Ž CLOe, Australia Diagnosis ith Pyloriset EIA-G III The nely developed EIA kit, Pyloriset EIA-G III assay uses microtiter ells coated ith inactive H. pylori antigens. In the present study, the assay procedure steps ere automated using the Biolab 300 Ž Meridian Diagnostics, Cincinnati, USA.. Serum samples ere diluted Ž 1:201. ith serum dilution buffer. Four undiluted calibration sera and diluted samples ere added to the ells, mixed, and incubated at 258C for 30 min. The plate as ashed three times ith ashing buffer, after hich conjugate Žperoxidase conjugated anti-human IgG Ž rabbit. as added to each ell. After mixing and a second incubation at 258C for 30 min, the plate as ashed

3 ( ) C.F. Weijnen et al.rjournal of Microbiological Methods X X again. Substrate Ž3,3,5,5 -tetramethylbenzidine. as then added to each ell and the plate mixed and incubated at 258C for 10 min. The reaction as stopped by adding the stopping solution Ž 1 M H SO. 2 4 and the absorbance of the assay as read at 450 nm. The optical densities of four reference standards ere used to plot a standard curve Ž straight line. by hich the H. pylori IgG antibody levels in patient samples ere quantified. The results ere expressed in arbitrary units per milliliter. Reference standards 1 4 represent 10, 20, 120, 640 Urml, respectively. The absorbance readings are proportional to the logarithm of the antibody concentration. Folloing the manufacturer s interpretation of the assay, the result should be considered positive for H. pylori antibodies if the Urml of the serum is equal or higher than that of the calibrator serum 2 Ž G 20 Urml.. To compare the ne ith the former H. pylori assay, the arbitrary units ere multiplied ith a factor 10 Ž recommended by the manufacturer. to reset these values in titer values as used in the former Pyloriset EIA-G ne kit. The total procedure time for the Pyloriset EIA-G III as 80 min Definition of the reference standard Patients ere considered to be H. pylori infected if at least to of the folloing three tests ere positive: Ž. 1 rapid urease test Ž CLOe.; Ž C urea breath test Ž CUBT.; and Ž 3. histology Analytical performance of the Pyloriset EIA-G III Precision Within-run precision as determined by using sera on three levels. Replicate measurements Ž n s 20. ere performed in one run for each level. This procedure as processed using a single reagent lot. The ithin-run precision data are expressed as coefficients of variation Ž CV, %.. Beteen-run precision as determined using sera on three levels. Replicate measurements Ž ns5. ere performed in different runs. A single reagent lot as used during the measurements. The beteen-run data ere expressed as CVs Linearity The linearity of the Pyloriset EIA-G III as assessed by calculation of the recovery of a repeatedly diluted high concentrate sample Ž ; 800 Urml Effect of rethaing sera on detection ith Pyloriset EIA-G III The possible effect of rethaing sera on the IgG antibody levels as tested ith sera at three levels. The sera have been thaed and frozen again for five times and analysed. The possible effect of rethaing is expressed as CV Correlation of tests Correlations beteen the qualitative test results Ž. i.e., positive or negative of the Pyloriset EIA-G III ith the CUBT, and Pyloriset EIA-G ne ere determined using Cohen s kappa Žmeasurement of agreement Statistical analysis The test characteristics ere reported in terms of sensitivity, specificity, positive and negative predictive values. Measurement of agreement as reported in terms of Cohen s kappa. Statistical analysis as performed using SPSS version 9.0 for Windos. 3. Results 3.1. Patients Beteen April 1999 and January 2000, 133 primary care patients ith dyspepsia ere included, and referred for H. pylori testing and endoscopical diagnosis. For 113 patients, complete data on both the EIA and the reference standard ere available. The H. pylori infection rate, according to the reference test Ž consisting of CUBT, CLO and histology., as 31.7% Validation against reference standard The observed negative and positive predictive values, sensitivities and specificities of the Pylori-

4 238 ( ) C.F. Weijnen et al.rjournal of Microbiological Methods Table 1 Characteristics of the Pyloriset EIA-G III at different cut-off levels in relation to the reference standard Ž 95% confidence interval. Cut-off value 20 Cut-off value 30 Cut-off value 35 Cut-off value 40 PPV 69.8 Ž Ž Ž Ž NPV 98.5 Ž Ž Ž Ž Sensitivity 97.4 Ž Ž Ž Ž Specificity 80.5 Ž Ž Ž Ž PPV: positive predictive value. NPV: negative predictive value. set EIA-G III assay are given in Table 1. Test characteristics ere determined at different cut-off levels Žabove hich an individual as considered to be H. pylori infected.. At cut-off levels for infection varying from Urml, positive predictive values ranged from 69.8% to 92.1%, negative predictive values from 96.3% to 98.6%, sensitivities from 87.5% to 97.4%, and specificities from 80.7% to 93.3% Analytical performance of the Pyloriset EIA-G III Precision The ithin-run precision data, expressed as CVs of the mean levels of 10, 133 and 503 Urml, ere 1.6%, 8.4% and 11.2%, respectively. At the mean levels of 11, 93 and 614 Urml, the beteen-run precision CVs ere 4.8%, 7.5% and 28.7%, respectively Linearity The calculated recovery data are shon in Table 2. Good linearity data ere observed, ith recovery data above 80% for all the to-, four- and eight-time dilutions. Table 2 Table demonstrating the results of dilution in terms of recovery using the Pyloriset EIA-G III Dilution Value Ž Urml. Recovery Ž %. A Ar Ar Ar Effect of rethaing sera on detection ith Pyloriset EIA-G III The CVs measured for the samples at mean levels of 10.5, 162 and 892 Urml, that had been thaed and frozen again, ere respectively 3.4%, 13.5% and 28.4% Correlation of tests The correlation Žcomparing qualitative test re-. sults beteen the breath test and Pyloriset EIA-G III as high: Cohen s kappa of This result as similar for cut-off levels of 35 or 40 Urml for the Pyloriset EIA-G III as level of proven infection. The correlation beteen the former Pyloriset EIA- G and the Pyloriset EIA-G III as high; Cohen s kappa of 0.97 or 0.98 Žusing cut-off values of 40 or 35 Urml, respectively.. 4. Discussion The ne Pyloriset is a reliable method to detect H. pylori infection in primary care. Test characteristics validated against a high quality reference standard are excellent, and correlation of results ith those of CUBT and the former EIA is good. The recommended cut-off value needs to be carefully reconsidered. The cut-off value of the former Pyloriset assay as given by the manufacturer as a titer of 300. Surprisingly for the Pyloriset EIA-G III assay, a cut-off value of 20 Urml is recommended by the manufacturer, here a value of 30 Urml as expected according to the factor 10 difference beteen the to assays. For use in clinical practice, supporting clinical decisions for individual

5 ( ) C.F. Weijnen et al.rjournal of Microbiological Methods Table 3 Percentage of patients incorrectly diagnosed in a population ith H. pylori infection rate of 40% at different cut-off levels Cut-off Cut-off Cut-off Cut-off level 20 level 30 level 35 level 40 False positive False negative patients, the optimal cut-off point should be guided mainly by the positive and negative predicted value of the test Ž PPV and NPV.. The fact that H. pylori diagnosis ill be mainly used in dyspepsia management to support ulcer detecting strategies Žin particular, endoscopy plus antibiotic treatment., puts even more emphasis on to need for a correct H. pylori test result, both positive and negative. Calculating the percentage of incorrectly diagnosed or missed H. pylori infections at different cut-off levels demonstrates the most efficient cut-off point in clinical dyspepsia management in primary care Ž Table 3.. At 40 Urml, only 5% of the patients are incorrectly diagnosed. Ž Validation of the former assay Pyloriset EIA-G Ne. in a similar primary care population resulted in a sensitivity of 91% and specificity 78% ŽLein-van den Broek et al., We used a more solid reference standard Žat least to out of three reference tests positive vs. only one reference test used by Lein-van den Broek et al., 1999., hich resulted in a sensitivity of 94.7% and specificity of 92.7%. The ne assay Ž EIA-G III. performs in a similar ay in terms of sensitivity, specificity, positive and negative predictive value as the former EIA-G Ne. A fe additional advantages of the ne EIA should be addressed. The total procedure time of the EIA-G III is 80 min vs. 160 min in the EIA-G Ne. In contrast to the former EIA, the EIA-G III has a straight calibration line, hich leads to accurate results in the hole calibration range. No disadvantages in comparison ith the former Pyloriset could be found. In conclusion, this ne serology assay is an accurate, reliable and inexpensive screening test for H. pylori infections in dyspeptic patients in a primary care population, but the cut-off level for use in primary care should be increased from 20 to 40 Urml. Acknoledgements This study as supported by a research grant from the Mediphos Medical Supplies Group ŽRen- kum, the Netherlands.. The authors ish to thank Ms. Sjannie Klerx, laboratory technician of the Stichting Artsenlaboratorium Utrecht, for the analysis of the sera. References Eslick, G.D., Lim, L.L., Byles, J.E., Xia, H.H., Talley, N.J., Association of Helicobacter pylori infection ith gastric carcinoma: a meta-analysis. Am. J. Gastroenterol. 94 Ž. 9, European Helicobacter Pylori Study Group, Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut 41 Ž. 1, Jones, R., Phillips, I., Felix, G., Tait, C., An evaluation of near-patient testing for Helicobacter pylori in general practice. Aliment. Pharmacol. Ther. 11 Ž. 1, Laheij, R.J., Straatman, H., Jansen, J.B., Verbeek, A.L., Evaluation of commercially available Helicobacter pylori serology kits: a revie. J. Clin. Microbiol. 36 Ž 10., Lein-van den Broek, N.T., Numans, M.E., Buskens, E., de Wit, N.J., Smout, A.J., Verheij, T.J., Validation and value of an enzyme-linked immunosorbent assay for Helicobacter pylori in primary care. Scand. J. Gastroenterol. 34 Ž. 4, Marshall, B.J., Warren, J.R., Unidentified curved bacilli in the stomach of patients ith gastritis and peptic ulceration. Lancet 16 ŽŽ , National Institutes of Health, Helicobacter pylori in peptic ulcer disease. NIH Consensus Statement 12, Parsonnet, J., Helicobacter pylori and gastric cancer. Gastroenterol. Clin. North Am. 22 Ž. 1, Peterson, W.L., Fendrick, A.M., Cave, D.R., Peura, D.A., Garabedian-Ruffalo, S.M., Laine, L., Helicobacter pylori-related disease: guidelines for testing and treatment. Arch. Intern. Med. 8 Ž160Ž 9.., Quartero, A.O., Numans, M.E., de Melker, R.A., de Wit, N.J., In-practice evaluation of hole-blood Helicobacter pylori test: its usefulness in detecting peptic ulcer disease. Br. J. Gen. Pract. 50 Ž 450., Savarino, V., Vigneri, S., Celle, G., The 13 C urea breath test in the diagnosis of Helicobacter pylori infection. Gut 45 Ž Suppl. 1., I18 I22 Revie.

6 240 ( ) C.F. Weijnen et al.rjournal of Microbiological Methods Vaira, D., Malfertheiner, P., Megraud, F., Axon, A.T., Deltenre, M., Hirschl, A.M., Gasbarrini, G., O Morain, C., Garcia, J.M., Quina, M., Tytgat, G.N., Diagnosis of Helicobacter pylori infection ith a ne noninvasive antigen-based assay group. Lancet 3 Ž354Ž , Wilcox, M.H., Dent, T.H., Hunter, J.O., Gray, J.J., Bron, D.F., Wight, D.G., Wraight, E.P., Accuracy of serology for the diagnosis of Helicobacter pylori infection a comparison of eight kits. J. Clin. Pathol. 49 Ž. 5,

New immunoassay for the detection of Helicobacter pylori infection compared with urease test,

New immunoassay for the detection of Helicobacter pylori infection compared with urease test, Chapter V New immunoassay for the detection of Helicobacter pylori infection compared with urease test, 13C breath test and histology: validation in the primary care setting Catherine F Weijnen 1, Henriëtte

More information

H.Pylori IgG

H.Pylori IgG DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com

More information

H.Pylori IgG Cat # 1503Z

H.Pylori IgG Cat # 1503Z DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

H. pylori Antigen ELISA Kit

H. pylori Antigen ELISA Kit H. pylori Antigen ELISA Kit Catalog Number KA3142 96 assays Version: 04 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle of

More information

H.pylori IgA Cat #

H.pylori IgA Cat # DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate

H. pylori IgM. Cat # H. pylori IgM ELISA. ELISA: Enzyme Linked Immunosorbent Assay. ELISA - Indirect; Antigen Coated Plate DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com H. pylori

More information

See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z

See external label 2 C-8 C Σ=96 tests Cat # 1505Z. MICROWELL ELISA H.Pylori IgA Cat # 1505Z DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

H.Pylori IgM Cat # 1504Z

H.Pylori IgM Cat # 1504Z DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

H. pylori IgM CLIA kit

H. pylori IgM CLIA kit H. pylori IgM CLIA kit Cat. No.:DEEL0251 Pkg.Size:96 tests Intended use Helicobacter pylori IgM Chemiluminescence ELISA is intended for use in evaluating the serologic status to H. pylori infection in

More information

Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia

Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients with Dyspepsia Gastroenterology Research and Practice Volume 2013, Article ID 184806, 5 pages http://dx.doi.org/10.1155/2013/184806 Research Article Performance of Routine Helicobacter pylori Invasive Tests in Patients

More information

Utility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings

Utility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings Original article: Utility of In House made Rapid Urease Broth Test for Detection of Helicobacter pylori Infection in Resource Constraint Settings 1.Dr. Swati Rahul Dhope, 2. Dr. Sachinkumar Vasantrao Wankhede

More information

Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study

Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study Aliment Pharmacol Ther 2005; 21: 485 489. doi: 10.1111/j.1365-2036.2005.02355.x Evaluation of a new rapid immunoassay for the detection of Helicobacter pylori in faeces: a prospective pilot study L. TREVISANI*,

More information

Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013

Urea Breath Test for Diagnosis of Helicobactor pylori. Original Policy Date 12:2013 MP 2.04.04 Urea Breath Test for Diagnosis of Helicobactor pylori Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date 12:2013 Return to Medical Policy Index

More information

Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT

Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in Detecting Helicobacter pylori Infection ABSTRACT Original Article Rojborwonwitaya J, Vijitjunyakul N THAI J GASTROENTEROL 2005 Vol. 6 No. 2 May - Aug. 2005 55 Comparison of the Accuracy of Two Commercial Rapid Urase Tests, CLOtest and Pronto Dry, in

More information

What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori?

What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori? What is the status of Sequential Therapy Versus Standard Triple- Drug Therapy in peptic ulcer disease in eradicating H pylori? Sequential Therapy Versus Standard Triple- Drug Therapy for Helicobacter pylori

More information

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. Noninvasive tests as a substitute for histology in the diagnosis of Helicobacter pylori infection Hahn M, Fennerty M B, Corless C L, Magaret N, Lieberman D A, Faigel D O Record Status This is a critical

More information

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

PDF hosted at the Radboud Repository of the Radboud University Nijmegen PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/48400

More information

Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans

Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans ISSN: 2319-7706 Volume 2 Number 7 (2013) pp. 63-68 http://www.ijcmas.com Original Research Article Comparative study of invasive methods for diagnosis of Helicobacter pylori in humans V.Subbukesavaraja

More information

An evaluation of whole blood testing for Helicobacter pylori in general practice

An evaluation of whole blood testing for Helicobacter pylori in general practice Aliment Pharmacol Ther 1998; 12: 641±645. An evaluation of whole blood testing for Helicobacter pylori in general practice N. J. TALLEY, J. R. LAMBERT*, S. HOWELL, H. H.-X. XIA, S. K. LIN* & L. AGREUS

More information

TRANSPARENCY COMMITTEE OPINION. 13 December 2006

TRANSPARENCY COMMITTEE OPINION. 13 December 2006 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 13 December 2006 HELIKIT 75 mg, powder for oral solution CIP : 343 132-1 Applicant : MAYOLY SPINDLER 13 Curea anhydrous

More information

Helicobacter pylori IgA ELISA Kit

Helicobacter pylori IgA ELISA Kit Helicobacter pylori IgA ELISA Kit Catalog Number KA0964 96 assays Version: 03 Intended for research use only www.abnova.com Table of Contents Introduction... 3 Intended Use... 3 Background... 3 Principle

More information

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia.

KEYWORDS Dyspepsia, Acid Peptic Disease, Helicobacter Pylori, Urease, Giemsa, Peptic Ulcer, Non-Ulcer Dyspepsia. INCIDENCE OF HELICOBACTER PYLORI WITH ACID PEPTIC DISEASE AND MALIGNANT CONDITIONS OF UPPER GASTROINTESTINAL TRACT IN A TERTIARY CENTRE - A PROSPECTIVE STUDY Karunamoorthy Rajachidambaram 1, Dinkaran Kaarthesan

More information

Helicobacter pylori: Diagnosis, treatment and risks of untreated infection

Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Helicobacter pylori: Diagnosis, treatment and risks of untreated infection Klaus Mönkemüller Department of Gastroenterology, Hepatology und Infectius Diseases Otto-von-Guericke University, Magdeburg bb

More information

Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar

Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar International Journal of Gastroenterology, Hepatology, Transplant & Nutrition Original Article Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar Hnin

More information

ReQuest H. Pylori IgG

ReQuest H. Pylori IgG Intended use 01-550H 96 Test Set Enzyme Immunoassay for the Detection of Anti- Helicobacter pylori IgG Antibodies in Human Serum The SeraQuest H. Pylori IgG is a qualitative enzyme immunoassay (EIA) kit

More information

ORIGINAL ARTICLE /j x

ORIGINAL ARTICLE /j x ORIGINAL ARTICLE.1111/j.1469-691.6.1514.x Comparison of the performance of serological kits for Helicobacter pylori infection with European and Asian study populations T. T. H. Hoang 1,4, A.-S. Rehnberg

More information

Helicobacter and gastritis

Helicobacter and gastritis 1 Helicobacter and gastritis Dr. Hala Al Daghistani Helicobacter pylori is a spiral-shaped gram-negative rod. H. pylori is associated with antral gastritis, duodenal (peptic) ulcer disease, gastric ulcers,

More information

MEDICAL POLICY EFFECTIVE DATE: 05/19/11 REVISED DATE: 05/24/12, 05/23/13 ARCHIVED DATE: 05/22/14 EDITED DATE: 05/28/15, 05/25/16, 05/18/17, 05/17/18

MEDICAL POLICY EFFECTIVE DATE: 05/19/11 REVISED DATE: 05/24/12, 05/23/13 ARCHIVED DATE: 05/22/14 EDITED DATE: 05/28/15, 05/25/16, 05/18/17, 05/17/18 MEDICAL POLICY SUBJECT: NON-INVASIVE HELICOBACTER PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: helicobacter_pylori_testing 01/01/2019 N/A 01/01/2020 01/01/2019 Policy Effective April 1, 2019 Description

More information

HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey

HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey International Journal of Infectious Diseases (2005) 9, 21 26 http://intl.elsevierhealth.com/journals/ijid HpSA fecoprevalence in patients suspected to have Helicobacter pylori infection in Istanbul, Turkey

More information

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009

Helicobacter Pylori Testing HELICOBACTER PYLORI TESTING HS-131. Policy Number: HS-131. Original Effective Date: 9/17/2009 Easy Choice Health Plan, Inc. Harmony Health Plan of Illinois, Inc. Missouri Care, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc. WellCare Health Insurance of Illinois,

More information

Helicobacter Connections. Barry Marshall

Helicobacter Connections. Barry Marshall Helicobacter Connections Barry Marshall The greatest obstacle to knowledge is not ignorance, it is the illusion of knowledge. Daniel Boorstein - Historian Peptic Ulcers Duodenal Ulcer (DU) Gastric Ulcer

More information

DYSPEPSIA is a common problem that often leads to consultation

DYSPEPSIA is a common problem that often leads to consultation Original papers A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome Nicoline T Lewin-van den Broek, Mattijs E Numans,

More information

instrument. When 13C-UBT positive value is greater than or equal to / - 0.4, the the subject can be 1. Data and methods details are as follows:

instrument. When 13C-UBT positive value is greater than or equal to / - 0.4, the the subject can be 1. Data and methods details are as follows: Application of 13 C-urea breath test in screening helicobacter pylori infection during health examination in Chengdu, Sichuan YANG Yan-hua. LIU Yu-ping. CHENG You-fu, SHUAI Ping. LU Qiao. ZHENG Xiao-xia,

More information

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori

Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori ORIGINAL ARTICLE Correlation Between Endoscopic and Histological Findings in Different Gastroduodenal Lesion and its Association with Helicobacter Pylori *A. Sultana 1, SM Badruddoza 2, F Rahman 3 1 Dr.

More information

Validation of western Helicobacter pylori IgG antibody assays in Korean adults

Validation of western Helicobacter pylori IgG antibody assays in Korean adults Journal of Medical Microbiology (2015), 64, 513 518 DOI 10.1099/jmm.0.000050 Validation of western Helicobacter pylori IgG antibody assays in Korean adults Sun-Young Lee, 1 Hee-Won Moon, 2 Mina Hur 2 and

More information

QUANTA Lite TM H. pylori IgA ELISA For In Vitro Diagnostic Use CLIA Complexity: High

QUANTA Lite TM H. pylori IgA ELISA For In Vitro Diagnostic Use CLIA Complexity: High QUANTA Lite TM H. pylori IgA ELISA 708720 For In Vitro Diagnostic Use CLIA Complexity: High Intended Use The QUANTA Lite TM H. pylori IgA kit is an enzyme-linked immunosorbent assay (ELISA) for the qualitative

More information

Intragastric Acidification Reduces the Occurrence of False-Negative Urea Breath Test Results in Patients Taking a Proton Pump Inhibitor

Intragastric Acidification Reduces the Occurrence of False-Negative Urea Breath Test Results in Patients Taking a Proton Pump Inhibitor THE AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 96, No. 4, 2001 2001 by Am. Coll. of Gastroenterology ISSN 0002-9270/01/$20.00 Published by Elsevier Science Inc. PII S0002-9270(01)02250-X Intragastric Acidification

More information

Rat Glicentin EIA FOR RESEARCH USE ONLY. <Distributed by> DF Kasumigaseki Place, 3-6-7, Kasumigaseki, Chiyoda-ku Tokyo Japan

Rat Glicentin EIA FOR RESEARCH USE ONLY. <Distributed by> DF Kasumigaseki Place, 3-6-7, Kasumigaseki, Chiyoda-ku Tokyo Japan YK111 Rat Glicentin EIA FOR RESEARCH USE ONLY DF Kasumigaseki Place, 3-6-7, Kasumigaseki, Chiyoda-ku Tokyo 100-0013 Japan URL: http://www.sceti.co.jp/export/ e-mail: exp-pet@sceti.co.jp

More information

CLIA Complexity for Whole Blood: WAIVED. Intended Use. Summary and Explanation

CLIA Complexity for Whole Blood: WAIVED. Intended Use. Summary and Explanation CLIA Complexity for Whole Blood: WAIVED Intended Use The is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies specific to Helicobacter pylori in whole blood. The

More information

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line)

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) For in vitro diagnostic use. CLIA Complexity for Whole Blood: WAIVED INTENDED USE The QuickVue H. pylori Test is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies

More information

THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN

THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN THE PREVALENCE OF HELICBACTER PYLORI AMONG PATIENTS COMPLAINING FROM ABDOMINAL PAIN Ahed J. Al-Khatib Jordan University of Science and Technology, Jordan Ahmed Saber Abu-zaiton Al-albayt University Abstract

More information

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) Reagents

Catalog # 0W009 0W010 Test Cassettes, murine monoclonal antibody to human IgG (Test Line) and rabbit polyclonal antibody (Control Line) Reagents For in vitro diagnostic use. CLIA Complexity: MODERATE INTENDED USE The QuickVue H. pylori Test is a lateral-flow immunoassay intended for the rapid, qualitative detection of IgG antibodies specific to

More information

Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens

Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens Helicobacter ISSN 1523-5378 Filipec Blackwell Oxford, HEL 1083-4389 1523-5378 Journal XXX Original H. 2008 pylori Kanizaj compilation The UK Eradication Publishing Article Authors et al. Ltd 2008 Therapy

More information

Helicobacter pylori Improved Detection of Helicobacter pylori

Helicobacter pylori Improved Detection of Helicobacter pylori DOI:http://dx.doi.org/10.7314/APJCP.2016.17.4.2099 RESEARCH ARTICLE Improved Detection of Helicobacter pylori Infection and Premalignant Gastric Mucosa Using Conventional White Light Source Gastroscopy

More information

The Nobel Prize in Physiology or Medicine for 2005

The Nobel Prize in Physiology or Medicine for 2005 The Nobel Prize in Physiology or Medicine for 2005 jointly to Barry J. Marshall and J. Robin Warren for their discovery of "the bacterium Helicobacter pylori and its role in gastritis and peptic ulcer

More information

Immunoglobulin G Antibody against Helicobacter pylori: Clinical Implications of Levels Found in Serum

Immunoglobulin G Antibody against Helicobacter pylori: Clinical Implications of Levels Found in Serum CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, Sept. 2002, p. 1044 1048 Vol. 9, No. 5 1071-412X/02/$04.00 0 DOI: 10.1128/CDLI.9.5.1044 1048.2002 Copyright 2002, American Society for Microbiology. All Rights

More information

Herpes Simplex Virus 2 IgM HSV 2 IgM

Herpes Simplex Virus 2 IgM HSV 2 IgM DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com

More information

Disclosures. Co-founder and Chief Science Officer, TechLab

Disclosures. Co-founder and Chief Science Officer, TechLab H. pylori testing Disclosures Co-founder and Chief Science Officer, TechLab Learning Objectives Evaluate the appropriate testing methodology by balancing performance, economics, and workflow. Discuss the

More information

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.05 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17, 2017 Next

More information

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35.

Helicobacter 2008;13:1-6. Am J Gastroent 2007;102: Am J of Med 2004;117:31-35. An Update on Helicobacter pylori and Its Treatment Trenika Mitchell, PharmD, BCPS Clinical Assistant Professor University of Kentucky College of Pharmacy October 18, 2008 Objectives Review the epidemiology

More information

(Index words: Clarithromycin, compliance, efficacy, tinidazole and omeprazole therapy)

(Index words: Clarithromycin, compliance, efficacy, tinidazole and omeprazole therapy) Comparison of one week and two weeks of triple therapy for the eradication of Helicobacter pylori in a Sri Lankan population: a randomised, controlled study HA de Silva 1, J Hewavisenthi 2, A Pathmeswaran

More information

CoproELISA TM H. pylori

CoproELISA TM H. pylori CoproELISA TM H. pylori Enzyme-Linked Immunosorbent Assay (ELISA) For the Detection of Helicobacter pylori antigens in human feces Instruction Manual Test kit for 96 determinations Catalog Number: 774-01

More information

For the convenience of storage, Cassette and Sample Tubes can be stored separately. OneStep. H.Pylori Antigen. RapiCard InstaTest.

For the convenience of storage, Cassette and Sample Tubes can be stored separately. OneStep. H.Pylori Antigen. RapiCard InstaTest. CORTEZ DIAGNOSTICS, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 USA Tel: (818) 591-3030 Fax: (818) 591-8383 E-mail: onestep@rapidtest.com Web site: www.rapidtest.com See external label

More information

Herpes Simplex Virus 2 IgG HSV 2 IgG

Herpes Simplex Virus 2 IgG HSV 2 IgG DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and 116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com

More information

COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION

COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Phil J Gastroenterol 2006; 2: 25-29 COMPARISON OF ONCE-A-DAY VERSUS TWICE-A-DAY CLARITHROMYCIN IN TRIPLE THERAPY FOR HELICOBACTER PYLORI ERADICATION Marianne P Collado, Ma Fatima P Calida, Peter P Sy,

More information

(Received September 12, Accepted April 23, 1997) Jpn. J. Med. Sci. Biol., 50, 55-62, 1997.

(Received September 12, Accepted April 23, 1997) Jpn. J. Med. Sci. Biol., 50, 55-62, 1997. Jpn. J. Med. Sci. Biol., 50, 55-62, 1997. EVALUATION OF CULTURE, HISTOLOGICAL EXAMINATION, SEROLOGY AND THE RAPID UREASE TEST FOR DIAGNOSIS OF HELICOBACTER PYLORI IN PATIENTS WITH DYSPEPSIA IN BANGLADESH

More information

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17, 2016 Next

More information

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 17, 2016 Next

More information

Comparative study of rapid urease test and histopathological examination for detection of H. pylori infection

Comparative study of rapid urease test and histopathological examination for detection of H. pylori infection International Surgery Journal Athavale VS et al. Int Surg J. 2017 Dec;4(12):4071-4075 http://www.ijsurgery.com pissn 2349-3305 eissn 2349-2902 Original Research Article DOI: http://dx.doi.org/10.18203/2349-2902.isj20175413

More information

H. pylori IgG Enzyme Immunoassay Test Kit For In Vitro Diagnostic Use Catalog No Tests

H. pylori IgG Enzyme Immunoassay Test Kit For In Vitro Diagnostic Use Catalog No Tests SUMMARY OF PROCEDURE H. pylori IgG Enzyme Immunoassay Test Kit For In Vitro Diagnostic Use Catalog No. 720-130 96 Tests 1. Prepare 1:21 dilutions of samples in Sample Diluent. Mix well. 2. Add 100 μl of

More information

Two Enzyme Immunoassays and PCR for Detection of Helicobacter pylori in Stool Specimens from Pediatric Patients before and after Eradication Therapy

Two Enzyme Immunoassays and PCR for Detection of Helicobacter pylori in Stool Specimens from Pediatric Patients before and after Eradication Therapy JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2000, p. 3710 3714 Vol. 38, No. 10 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Two Enzyme Immunoassays and PCR for

More information

Toxoplasma gondii IgM (Toxo IgM)

Toxoplasma gondii IgM (Toxo IgM) DIAGNOSTIC AUTOMATION, INC. 21250 Califa Street, Suite 102 and116, Woodland Hills, CA 91367 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com

More information

Human Obestatin ELISA

Human Obestatin ELISA K-ASSAY Human Obestatin ELISA For the quantitative determination of obestatin in human serum and plasma Cat. No. KT-495 For Research Use Only. 1 Rev. 081309 K-ASSAY PRODUCT INFORMATION Human Obestatin

More information

Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe

Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs Prof. Sheila Crowe Acid-Peptic Diseases of the Stomach and Duodenum Including Helicobacter pylori and NSAIDs 1 Division of Gastroenterology UC San Diego School of Medicine Clinical presentations of Helicobacter pylori infection

More information

Peptic Ulcer Disease Update

Peptic Ulcer Disease Update Peptic Ulcer Disease Update Col Pat Storms RAM 2005 Disclosure Information 84th Annual AsMA Scientific Meeting Col Patrick Storms I have no financial relationships to disclose. I will discuss the following

More information

Clinical Policy: Helicobacter Pylori Serology Testing Reference Number: CP.MP.153

Clinical Policy: Helicobacter Pylori Serology Testing Reference Number: CP.MP.153 Clinical Policy: Reference Number: CP.MP.153 Effective Date: 12/17 Last Review Date: 12/17 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

See external label 96 tests HSV 2 IgA. Cat #

See external label 96 tests HSV 2 IgA. Cat # DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Evaluation of Three Commercial Enzyme Immunoassays Compared with the 13 C Urea Breath Test for Detection of Helicobacter pylori Infection

Evaluation of Three Commercial Enzyme Immunoassays Compared with the 13 C Urea Breath Test for Detection of Helicobacter pylori Infection JOURNAL OF CLINICAL MICROBIOLOGY, May 1996, p. 1147 1152 Vol. 34, No. 5 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Evaluation of Three Commercial Enzyme Immunoassays Compared

More information

Clinical Policy Title: Noninvasive testing for H. pylori

Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Title: Noninvasive testing for H. pylori Clinical Policy Number: 08.01.05 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: July 3, 2018 Next

More information

Application of immunoassay for detection of Helicobacter pylori antigens in the dental plaque

Application of immunoassay for detection of Helicobacter pylori antigens in the dental plaque Advances in Medical Sciences Vol. 54(2) 2009 pp 194-198 DOI: 10.2478/v10039-009-0050-3 Medical University of Bialystok, Poland Application of immunoassay for detection of Helicobacter pylori antigens in

More information

in Pregnancy ABSTRACT

in Pregnancy ABSTRACT Infectious Diseases in Obstetrics and Gynecology 7:195-198 (1999) (C) 1999 Wiley-Liss, Inc. Increased Susceptibility to Helicobacter pylori Infection in Pregnancy S. Lanciers,,2 B. Despinasse, 1 D.I. Mehta,

More information

Mouse GLP-2 EIA. Cat. No. KT-374. For the quantitative determination of GLP-2 in mouse serum or plasma. For Research Use Only. 1 Rev.

Mouse GLP-2 EIA. Cat. No. KT-374. For the quantitative determination of GLP-2 in mouse serum or plasma. For Research Use Only. 1 Rev. Mouse GLP-2 EIA For the quantitative determination of GLP-2 in mouse serum or plasma. Cat. No. KT-374 For Research Use Only. 1 Rev. 11357374 PRODUCT INFORMATION Mouse GLP-2 EIA Cat. No. KT-374 INTENDED

More information

Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師

Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師 Helicobacter pylori 幽門螺旋桿菌 馬偕紀念醫院新竹分院一般內科, 肝膽腸胃科陳重助醫師 Hp : Helicobacter pylori Part 1. Pathophysiology and immune response Pathogenesis of Hp infection Part 2. Clinical manifestation Part 3. Dx tests for

More information

Imprint cytology: a simple, cost effectiveness analysis for diagnosing Helicobacter pylori, in west of Iran

Imprint cytology: a simple, cost effectiveness analysis for diagnosing Helicobacter pylori, in west of Iran Original Research Medical Journal of Islamic Republic of Iran, Vol. 26, No. 1, Feb. 2012, pp. 12-16 Imprint cytology: a simple, cost effectiveness analysis for diagnosing Helicobacter pylori, in west of

More information

Research Article Reliability of Diagnostic Tests for Helicobacterpylori Infection

Research Article Reliability of Diagnostic Tests for Helicobacterpylori Infection Gastroenterology Research and Practice Volume 211, Article ID 946, 6 pages doi:1.1155/211/946 Research Article Reliability of Diagnostic Tests for Helicobacterpylori Infection S. Redéen, 1, 2 F. Petersson,

More information

Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy

Stool antigen tests in the diagnosis of Helicobacter pylori infection before and after eradication therapy PO Box 2345, Beijing 100023, China World J Gastroenterol 2005;11(46):7340-7344 www.wjgnet.com World Journal of Gastroenterology ISSN 1007-9327 wjg@wjgnet.com ELSEVIER 2005 The WJG Press and Elsevier Inc.

More information

Clinical Policy Title: Breath Testing for H. Pylori

Clinical Policy Title: Breath Testing for H. Pylori Clinical Policy Title: Breath Testing for H. Pylori Clinical Policy Number: 08.01.04 Effective Date: January 1, 2016 Initial Review Date: August 19, 2015 Most Recent Review Date: August 19, 2015 Next Review

More information

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes

See external label 2 C-8 C 96 tests Chemiluminescence. CMV IgM. Cat # Diluted samples, controls & calibrator 100 µl 30 minutes DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

Comparison of stool antigen and urea breath test (UBT) methods for detection of Helicobacter pylori infection and the risk factors

Comparison of stool antigen and urea breath test (UBT) methods for detection of Helicobacter pylori infection and the risk factors International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 3, Issue 12-2017 Comparison of stool

More information

Dog Insulin ELISA Kit (TMB)

Dog Insulin ELISA Kit (TMB) Dog Insulin ELISA Kit (TMB) Research Reagent [Advantage] Please, read this instruction carefully before use. (1) Dog Insulin Kit is a high speed EIA. (for 3-4 hours). (2) Dog Insulin Kit can measure in

More information

Breath Test Diagnosis of Helicobacter pylori in Peptic Ulcer Disease: A Noninvasive Primary Care Option

Breath Test Diagnosis of Helicobacter pylori in Peptic Ulcer Disease: A Noninvasive Primary Care Option ORIGINAL ARTICLES Breath Test Diagnosis of Helicobacter pylori in Peptic Ulcer Disease: A Noninvasive Primary Care Option Michael W Felz, MD, George] Burke, MD, and Bernard M. Schuman, MD Background: Hellcobacter

More information

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer

Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer 618 University Department of Medicine and Therapeutics, Western Infirmary, Glasgow G11 6NT, UK K E L McColl A El-Nujumi L S Murray E M El-Omar A Dickson A W Kelman T E Hilditch Correspondence to: Professor

More information

Oral Fluid Antibody Detection in the Diagnosis of Gastric Helicobacter pylori Infection

Oral Fluid Antibody Detection in the Diagnosis of Gastric Helicobacter pylori Infection Oral Fluid Antibody Detection in the Diagnosis of Gastric Helicobacter pylori Infection Behzad Hooshmand 1, Alireza Monsef 2, Mohammad Amirmadglesi 3, and Mani Kashani 4 1 Department of Periodontology

More information

Helicobacter pylori:an Emerging Pathogen

Helicobacter pylori:an Emerging Pathogen Bacteriology at UW-Madison Bacteriology 330 Home Page Helicobacter pylori:an Emerging Pathogen by Karrie Holston, Department of Bacteriology University of Wisconsin-Madison Description of Helicobacter

More information

CerTest Turbilatex. A quantitative immunological latex method. FOB Calprotectin Transferrin H. pylori

CerTest Turbilatex. A quantitative immunological latex method. FOB Calprotectin Transferrin H. pylori CerTest Turbilatex A quantitative immunological latex method FOB Calprotectin Transferrin H. pylori Turbidimetric technique. A latex turbidimetric assay The turbidimetric assay is based on the agglutination

More information

MALT LYMPHOMA. Silvia Montoto, St Bartholomew s Hospital, London, UK ESMO Preceptorship on Lymphoma

MALT LYMPHOMA. Silvia Montoto, St Bartholomew s Hospital, London, UK ESMO Preceptorship on Lymphoma MALT LYMPHOMA Silvia Montoto, St Bartholomew s Hospital, London, UK ESMO Preceptorship on Lymphoma Lugano, 3-4 November 2017 Disclosures: Roche: honoraria Gilead: travel grant ESMO Preceptorship on Lymphoma

More information

Comparing furazolidone and tetracycline in quadruple therapy for eradication helicobacter pylori in dyspepsia patients

Comparing furazolidone and tetracycline in quadruple therapy for eradication helicobacter pylori in dyspepsia patients Gastroenterology and Hepatology from bed to bench. 2008;1(1):39-43 2008 RCGLD, Research Center for Gastroenterology and Liver Diseases ORIGINAL ARTICLE Comparing furazolidone and tetracycline in quadruple

More information

Estrone EIA kit. For the quantitative determination of estrone in dried fecal extracts, urine and tissue culture media. Cat. No.

Estrone EIA kit. For the quantitative determination of estrone in dried fecal extracts, urine and tissue culture media. Cat. No. K-ASSAY KAMIYA BIOMEDICAL COMPANY KAMIYA BIOMEDICAL COMPANY Estrone EIA kit For the quantitative determination of estrone in dried fecal extracts, urine and tissue culture media Cat. No. KT-720 For Research

More information

Papers. Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study.

Papers. Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study. Testing for Helicobacter pylori in dyspeptic patients suspected of peptic ulcer disease in primary care: cross sectional study Catherine F Weijnen, Mattijs E Numans, Niek J de Wit, André JPMSmout, Karel

More information

Helicobacter pylori: drowning in a pool of blood?

Helicobacter pylori: drowning in a pool of blood? Helicobacter pylori: drowning in a pool of blood? Diagnosis of Helicobacter pylori infection is crucial in the short-term and long-term management of patients with bleeding ulcers. If a patient with ulcer

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Adherence, to bismuth quadruple therapy, 543 546 Adjuvant therapy, probiotics as, 567 569 Age factors, in gastric cancer, 611 612, 616 AID protein,

More information

EDUCATION PRACTICE. Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? Clinical Scenario.

EDUCATION PRACTICE. Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? Clinical Scenario. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2008;6:1086 1090 EDUCATION PRACTICE Persistent Helicobacter pylori Infection After a Course of Antimicrobial Therapy What s Next? RICHARD J. SAAD* and WILLIAM D.

More information

Maastricht Ⅴ /Florence

Maastricht Ⅴ /Florence 2016 21 10 577 Maastricht Ⅴ /Florence 200001 2015 10 8 9 Maastricht V 1 / 2 3 4 / 5 Maastricht Ⅴ Interpretation of Management of Helicobacter pylori Infection the Maastricht Ⅴ / Florence Consensus Report

More information

See external label 2 C-8 C 96 tests CHEMILUMINESCENCE. CMV IgG. Cat # Step (20-25 C Room temp.) Volume

See external label 2 C-8 C 96 tests CHEMILUMINESCENCE. CMV IgG. Cat # Step (20-25 C Room temp.) Volume DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external

More information

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School

PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD. Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School PEPTIC ULCER DISEASE JOHN R SALTZMAN, MD Director of Endoscopy Brigham and Women s Hospital Professor of Medicine Harvard Medical School No disclosures Disclosures Overview Causes of peptic ulcer disease

More information

594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications

594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications 594 Lewin, Weinstein, and Riddell s Gastrointestinal Pathology and Its Clinical Implications Figure 13-20. Stages in the natural history of H. pylori. Biopsies from the antrum are on the left and the oxyntic

More information

H. pylori Stool Rapid Test (Cassette)

H. pylori Stool Rapid Test (Cassette) H. pylori Stool Rapid Test (Cassette) Cat. No.:DTS590 Pkg.Size: Intended use The H. pylori Stool Cassette is an immunochromatographic screening assay for the qualitative detectionof Helicobacter pylori

More information

JMSCR Vol 05 Issue 08 Page August 2017

JMSCR Vol 05 Issue 08 Page August 2017 www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i8.83 Role of Special Stain Giemsa in Demonstration

More information